I"G<p><strong>JUDGES</strong></p>
<p><strong>Peter Lurie&nbsp;</strong></p>
<p>Associate Commissioner/ FDA Public Health Strategy and Analysis, Food and Drug Administration</p>
<p><strong>Bakul Patel&nbsp;</strong></p>
<p>Associate Director for Digital Health/ Center for Devices and Radiological Health, Food and Drug Administration</p>
<p><strong>Wilson Compton&nbsp;</strong></p>
<p>Deputy Director/ National Institute on Drug Abuse</p>
<p><strong>Sean Khozin&nbsp;</strong></p>
<p>Medical Officer/Food and Drug Administration</p>
<p><strong>Gregorio Vasquez&nbsp;</strong></p>
<p>Information Technology Supervisor/Food and Drug Administration</p>
<p><strong>Natalia Martin&nbsp;</strong></p>
<p>Chief Information Officer Technical Advisor/Food and Drug Administration</p>
<p><strong>CRITERIA</strong></p>
<p><strong>Innovation&nbsp;- 25%</strong></p>
<p>Uniqueness and innovation in use of software and data analytics to fulfill the mandatory requirements; variety and value of additional features.</p>
<p><strong>Usability&nbsp;- 25%</strong></p>
<p>Use of design elements to increase utilization among both people at risk of opioid overdose and naloxone carriers; ease of navigation; appropriate use of an interface to support the app in achieving desired outcome.</p>
<p><strong>Functionality&nbsp;- 25%</strong></p>
<p>Potential to enhance the frequency and speed of naloxone administration by the carriers to the overdose victims.</p>
<p><strong>Adaptability&nbsp;- 25%</strong></p>
<p>Potential for app to be tailored to the practical environment (e.g., urban, rural) of an individual community.</p>
:ET